X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1055) 1055
Newsletter (199) 199
Publication (149) 149
Newspaper Article (22) 22
Book Review (18) 18
Book Chapter (17) 17
Book / eBook (3) 3
Conference Proceeding (3) 3
Dissertation (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (854) 854
index medicus (515) 515
fanconi's anemia (436) 436
cancer (370) 370
female (364) 364
oncology (308) 308
research (274) 274
male (270) 270
dna repair (256) 256
animals (233) 233
fanconi-anemia (226) 226
dna damage (224) 224
genetic aspects (197) 197
fanconi anemia (195) 195
fanconi anemia - genetics (189) 189
child (186) 186
hematology (175) 175
fanconi anemia - drug therapy (161) 161
care and treatment (158) 158
dna (146) 146
proteins (140) 140
cell line, tumor (138) 138
mutation (137) 137
article (134) 134
homologous recombination (130) 130
mice (129) 129
adult (126) 126
child, preschool (126) 126
cell biology (122) 122
anemia (120) 120
biochemistry & molecular biology (118) 118
deoxyribonucleic acid--dna (118) 118
health aspects (118) 118
transplantation (114) 114
chemotherapy (113) 113
adolescent (110) 110
fanconi anemia - therapy (108) 108
genetics & heredity (101) 101
genes (99) 99
fanconi syndrome (98) 98
stem cells (88) 88
breast cancer (87) 87
drug therapy (86) 86
fanconi anemia - metabolism (86) 86
tumors (86) 86
pediatrics (85) 85
repair (84) 84
fanconi anemia - complications (80) 80
fanconi anemia - pathology (79) 79
reports (77) 77
apoptosis (74) 74
cell cycle (74) 74
middle aged (74) 74
gene expression (73) 73
analysis (72) 72
hematopoietic stem cells (71) 71
genetic research (70) 70
oncology, experimental (70) 70
antineoplastic agents - pharmacology (69) 69
fanconi anemia complementation group d2 protein - metabolism (67) 67
bone marrow (66) 66
fanconi-anemia pathway (66) 66
medicine, research & experimental (66) 66
leukemia (65) 65
risk factors (64) 64
double-strand breaks (63) 63
multidisciplinary sciences (63) 63
medical research (62) 62
medicine (62) 62
cells (61) 61
dna repair - drug effects (61) 61
hemic and lymphatic diseases (60) 60
pathway (60) 60
neoplasms - genetics (59) 59
research article (58) 58
signal transduction (58) 58
neoplasms - drug therapy (57) 57
cell line (56) 56
cisplatin (56) 56
genetics (56) 56
breast-cancer (55) 55
infant (55) 55
antineoplastic agents - therapeutic use (54) 54
cross-link repair (54) 54
genomic instability (54) 54
aged (53) 53
fanconi anemia complementation group proteins - metabolism (53) 53
mitomycin - pharmacology (53) 53
physiological aspects (53) 53
therapy (53) 53
diagnosis (52) 52
drugs (52) 52
poly polymerase (52) 52
gene therapy (51) 51
review (51) 51
biology (50) 50
dna-repair (50) 50
fanconi anemia complementation group proteins - genetics (50) 50
expression (49) 49
fanconi anemia complementation group d2 protein - genetics (49) 49
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1257) 1257
French (9) 9
German (7) 7
Spanish (7) 7
Chinese (4) 4
Polish (2) 2
Russian (2) 2
Croatian (1) 1
Italian (1) 1
Japanese (1) 1
Romanian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal of Cellular Physiology, ISSN 0021-9541, 02/2018, Volume 233, Issue 2, pp. 1736 - 1751
Metformin (MET) is the drug of choice for patients with type 2 diabetes and has been proposed for use in cancer therapy and for treating other metabolic... 
metformin | energetic metabolism | Fanconi anemia | cancerogenesis | oxidative stress | POLYCYSTIC-OVARY-SYNDROME | PHYSIOLOGY | MITOCHONDRIAL ACTIVITY | PROTECTION | CLINICAL PHARMACOKINETICS | CANCER | DEFICIENCY | CELL BIOLOGY | BIOGENESIS | COMPLEX I DEFECTS | EXPRESSION | Lymphocytes - metabolism | Sirtuin 1 - metabolism | Cell Survival - drug effects | AMP-Activated Protein Kinases - metabolism | Leukemia - pathology | Fanconi Anemia - metabolism | Humans | Metformin - pharmacology | Leukemia - drug therapy | Leukemia - metabolism | Metformin - toxicity | Case-Control Studies | Dose-Response Relationship, Drug | Oxidative Phosphorylation - drug effects | Lymphocytes - pathology | Lymphocytes - drug effects | HL-60 Cells | Fanconi Anemia - pathology | DNA Damage | Enzyme Activation | Oxidative Stress - drug effects | Fanconi Anemia - drug therapy | Energy Metabolism - drug effects | Type 2 diabetes | Glucose metabolism | Medical research | DNA damage | Analysis | Leukemia | Medicine, Experimental | Hypoglycemic agents | Fanconi's anemia | Oxidative stress | Phosphorylation | Low concentrations | Anemia | Diabetes mellitus | Cytology | Tumor cell lines | Metabolism | Fanconi syndrome | Patients | SIRT1 protein | DNA repair | Cell morphology | Promyeloid leukemia | Oxidative phosphorylation | Drug metabolism | Metformin | Electron transport | Metabolic disorders | Deoxyribonucleic acid--DNA | Cancer | Index Medicus
Journal Article
American Journal of Hematology, ISSN 0361-8609, 08/2015, Volume 90, Issue 8, pp. 702 - 708
Immune function abnormalities have been reported in patients with Fanconi anemia (FA), dyskeratosis congenita (DC) and, rarely, in Shwachman–Diamond syndrome... 
RESPONSES | IN-VITRO | COLONY-STIMULATING FACTOR | FANCONI-ANEMIA PATIENTS | DYSKERATOSIS-CONGENITA | MONONUCLEAR-CELLS | VIRUS-LIKE PARTICLES | NECROSIS-FACTOR-ALPHA | HEMATOLOGY | APLASTIC-ANEMIA | IMMUNODEFICIENCY | Hemoglobinuria, Paroxysmal - congenital | Dyskeratosis Congenita - drug therapy | Humans | Lipomatosis - congenital | Child, Preschool | Male | Anemia, Aplastic | Exocrine Pancreatic Insufficiency - diagnosis | Adrenal Cortex Hormones - therapeutic use | Exocrine Pancreatic Insufficiency - immunology | Dyskeratosis Congenita - diagnosis | T-Lymphocytes - drug effects | Tumor Necrosis Factor-alpha - immunology | Fanconi Anemia - pathology | B-Lymphocytes - pathology | Anemia, Diamond-Blackfan - pathology | Hemoglobinuria, Paroxysmal - diagnosis | Child | Membrane Proteins - biosynthesis | B-Lymphocytes - immunology | Anemia, Diamond-Blackfan - drug therapy | Bone Marrow Diseases - immunology | Adolescent | Bone Marrow Diseases - congenital | Lipomatosis - diagnosis | T-Lymphocytes - immunology | Fanconi Anemia - immunology | Killer Cells, Natural - drug effects | Granulocyte Colony-Stimulating Factor - immunology | Tumor Necrosis Factor-alpha - biosynthesis | Bone Marrow Diseases - diagnosis | Anemia, Diamond-Blackfan - immunology | Infant | Killer Cells, Natural - pathology | Case-Control Studies | Hemoglobinuria, Paroxysmal - immunology | Bone Marrow Diseases - drug therapy | Phytohemagglutinins - pharmacology | Killer Cells, Natural - immunology | Adult | Female | T-Lymphocytes - pathology | Immunoglobulins - biosynthesis | Cytokines - immunology | Exocrine Pancreatic Insufficiency - drug therapy | Lipomatosis - drug therapy | Membrane Proteins - immunology | Anemia, Diamond-Blackfan - diagnosis | Lipomatosis - immunology | B-Lymphocytes - drug effects | Fanconi Anemia - diagnosis | Granulocyte Colony-Stimulating Factor - biosynthesis | Interferon-gamma - immunology | Hemoglobinuria, Paroxysmal - drug therapy | Dyskeratosis Congenita - pathology | Family | Aged | Primary Cell Culture | Fanconi Anemia - drug therapy | Dyskeratosis Congenita - immunology | Cytokines - biosynthesis | Exocrine Pancreatic Insufficiency - congenital | Interferon-gamma - biosynthesis | immune deficiency | cytokines | Inherited bone marrow failure syndromes
Journal Article
Journal Article
Cancer Research, ISSN 0008-5472, 09/2013, Volume 73, Issue 17, pp. 5497 - 5507
Journal Article
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2016, Volume 23, Issue 2, pp. 310 - 317
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 03/2015, Volume 62, Issue 3, pp. 463 - 470
Journal Article
Oncology Reports, ISSN 1021-335X, 03/2017, Volume 37, Issue 3, pp. 1842 - 1848
Acute myeloid leukemia and head and neck squamous cell carcinomas are the major causes of mortality and morbidity in Fanconi anemia (FA) patients. Matrix... 
Fanconi anemia fibroblasts | Inhibitors | Matrix metalloproteinases | Cytokines | Inducers | VITAMIN-C | inhibitors | TUMOR INVASION | STRAND BREAK REPAIR | METASTASIS | CARCINOMA CELLS | N-ACETYLCYSTEINE | GREEN TEA | IN-VITRO | ONCOLOGY | inducers | CANCER-CELL LINES | cytokines | matrix metalloproteinases | EXPRESSION | Enzyme Activators - pharmacology | Gene Expression Regulation, Enzymologic - drug effects | Fibroblasts - enzymology | Interleukin-1beta - pharmacology | Tetradecanoylphorbol Acetate - pharmacology | Humans | Carcinogens - pharmacology | Cattle | Fanconi Anemia - enzymology | Fanconi Anemia - pathology | Matrix Metalloproteinase 9 - secretion | Antineoplastic Agents - pharmacology | Catechin - pharmacology | Tretinoin - pharmacology | Cells, Cultured | Antioxidants - pharmacology | Fibroblasts - pathology | Matrix Metalloproteinase Inhibitors - pharmacology | Tumor Necrosis Factor-alpha - pharmacology | Animals | Fibroblasts - drug effects | Lipopolysaccharides - pharmacology | Doxycycline - pharmacology | Matrix Metalloproteinase 2 - secretion | Anti-Bacterial Agents - pharmacology | Catechin - analogs & derivatives | Fanconi Anemia - drug therapy | Cytokines - pharmacology | Care and treatment | Proteases | Development and progression | Genetic aspects | Health aspects | Fanconi's anemia | Tea | Acids | Anemia | Penicillin | Fibroblasts | Tumor necrosis factor-TNF | Metastasis | Cancer | Index Medicus
Journal Article
Journal Article